Neuroverses builds high-channel-count cortical interfaces and the closed-loop exoskeletal systems that listen back. We work at the seam between dense neural recording, embodied control, and the slow craft of making instruments scientists actually trust.
For most of the last decade, the bottleneck in motor neuroscience and rehabilitation was not theory but instrumentation — too few channels, too much drift, too little dialogue between the cortex and the machine that carried the body.
We design from the other side of that constraint: assume tens of thousands of stable channels, assume sub-millisecond closed loops, assume an exoskeleton that does not merely amplify intention but negotiates with it. The work that follows is what such an assumption demands.
Our practice is split between three benches and one shared telemetry room. We publish the parts of our work that benefit from being public, and we keep the rest in the lab where it belongs. We are uninterested in the demo cycle.
Most of what we ship is invisible from the outside: jigs, cabling, drivers, calibration rigs, training protocols, and the patient years of arguing with our own data.
A flexible, high-density cortical interface family designed for chronic stability without the surgical theatre. Helix targets motor and parietal cortex with low-modulus shanks, on-shank multiplexing, and a quiet, optically isolated headstage suited to long primate and human studies.
A lower-limb exoskeletal platform built around series-elastic actuators, distributed IMU sensing, and a control stack that treats human intention as a noisy collaborator rather than a command. Atlas is what we wear when we want to know what the neural signal is actually for.
The middleware that lets Helix and Atlas finish each other's sentences. Choir is a deterministic, real-time bus for spike sorting, intent decoding, and joint-level command shaping — designed so that the latency budget of an entire experiment fits inside a single motor-cortex burst.
We work with a small number of academic groups, clinical partners, and independent labs each year. We respond to every serious inquiry, usually within a week, and we keep our roadmap short on purpose.